Surgical Oncology chief Ismail Jatoi, MD, PhD, discusses Angelina Jolie's preventive mastectomy and the BRAC1 and BRAC2 genetic predisposition for breast and ovarian cancer for KSAT-12: In an effort to lower her risk of breast cancer, actress & celebrity Angelina Jolie underwent a double mastectomy and breast reconstruction in February. What might sound quite radical actually is not – Dr. Jatoi explains the role of genetic testing in preventing breast and ovarian cancer, and presents some of the treatment options available to women who have one or both of the genetic predisposition markers. Dr. Jatoi's interview | Angelina Jolie - In her words | More about Dr. Jatoi (5-15-13)
Ismail Jatoi, MD, PhD, Chief of Surgical Oncology and Endocrine Surgery, invited speaker at international breast cancer conference: Dr. Jatoi spoke on 'Breast conserving therapy - Indications, margins and modern aspects,' at the American University of Beirut Breast Cancer Conference in Beirut, Lebanon in February. The conference was held in collaboratiojn with the Lebanese Society of General Surgery, the American College of Surgeons - Lebanese Chapter, and the Lebanese Society of Radiation Oncology. More about Dr. Jatoi (12-19-12)
Boyce Oliver, Jr., MD, attends ACGME site visit: Dr. Oliver, Professor of Surgical Oncology and Endocrine Surgery, attended the Accreditation Council for Graduate Medical Education (ACGME) visit on February 11, 2013. ACGME site visits are intended to be collegial and education experiences for programs and sponsoring institutions, as well as to be helpful to program directors. More about Dr. Oliver | (12-19-12)
Ismail Jatoi, MD, PhD, Chief of Surgical Oncology and Endocrine Surgery interviewed by BreastCancerAnswers.com: Jay K. Harness, MD medical director of BreastCancerAnswers.com, interviewed Dr. Jatoi December 6, 2012, regarding the use of pre-operative breast MRI in patients with newly diagnosed breast cancers. View interview on BreastCancerAnswers.com | View more San Antonio Breast Cancer Symposium interviews on YouTube | More about Dr. Jatoi (12-11-12)
Ismail Jatoi, MD, PhD, Chief of Surgical Oncology and Endocrine Surgery interviewed on Texas Public Radio: Dr. Jatoi discussed pre-surgical MRI for a report on the San Antonio Breast Cancer Symposium, held in December 2012. Dr. Jatoi moderated a panel on 'Controversies in the Surgical Management of Breast Cancer', which included topics 'Sentinel node biopsy in breast cancer - before or after neoadjuvant chemotherapy', Evolving trends in implant breast reconstruction', and Dr. Jatoi's topic, 'The role of MRI in management of primary breast cancer'. More about Dr. Jatoi (12-5-12)
Boyce Oliver, Jr., MD, appointed to Commission on Cancer position: The American College of Surgeons has announced the 3-year appointment of Dr. Oliver, Professor of Surgical Oncology in the Division of Surgical Oncology and Endocrine Surgery, as Cancer Liaison Physician for the cancer program at University Health System. Cancer Liaison Physicians are an integral part of cancer programs accredited by the ACS Commission on Cancer. Dr. Oliver is a member of the multidisciplinary cancer committee at University Health System, and has a significant interest in the diagnosis and treatment of patients with malignant diseases. More about Dr. Oliver | More info on FACS Commission on Cancer | Read FACS press release (11-14-12)
Ismail Jatoi, MD, PhD, FACS, Professor and Chief, Division of Surgical Oncology and Endocrine Surgery, speaker for General Surgery Grand Rounds: Dr. Jatoi will be presenting 'Management of ductal carcinoma in situ' on Monday November 19, 2012, at 7 am in room 409L of the School of Medicine. More about Dr. Jatoi | More information on UT General Surgery Grand Rounds (11-13-12)
Ismail Jatoi, MD, PhD, FACS, Professor and Chief, Division of Surgical Oncology and Endocrine Surgery, receives Texas Surgical Society award: During the October 2012 annual meeting of the Society, Dr. Jatoi was awarded the James E. Thompson Award for best paper by a new member for his article is entitled,'Breast cancer adjuvant therapy: Assessing short term and long term benefits'. More about Dr. Jatoi | More about the Texas Surgical Society (10-30-12)
Thelma Hurd, MD, FACS, Associate Professor of Surgery in the Division of Surgical Oncology and Endocrine Surgery, presented 'Hispanic Women, Screening and Triple Negative Breast Cancer: Where Access and Biology Collide', at the inaugural Surgical Healthcare Disparities meeting in Baltimore Md. Co-sponsored by the Society of Black Academic Surgeons, Johns Hopkins and Howard University, this is the first healthcare disparities symposium focused on surgical issues in underserved populations held in the United States. More about Dr. Hurd (4-18-12)
Founding faculty interviews available online: Thanks to a collaborative effort between the UT Health Science Center Libraries, the School of Medicine, the Alumni Association, and the Office of Development, you can now watch video interviews of the founding faculty, including Surgery's Anatolio Cruz, MD. View interviews (4-5-12)
School of Medicine's Winter 2011 FUTURE magazine features our military partnership: The relationship between the School of Medicine and the Department of Surgery with San Antonio's military presence began more than 40 years ago. The article focuses on the ongoing contributions and collaborations between our healthcare training and patient care, and the members of the military who continue to contribute. Several Department of Surgery faculty are featured, including Ismail Jatoi, MD, Chief of Surgical Oncology and Endocrine Surgery, and Anatolio Cruz, MD, Professor of Surgical Oncology and Endocrine Surgery. Read/download FUTURE Winter 2012 (4-5-12)
Ismail Jatoi, MD, PhD, Chief of Surgical Oncology and Endocrine Surgery quoted in United Nations publication: Dr. Jatoi quoted in an article, 'The true burden of cancer', in IRIN News, an online publication of the United Nations Office for the Coordination of Humanitarian Affairs. Dr. Jatoi comments on breast cancer clinical trials in lower and middle-income countries could help boost tracking and prevention of breast cancer. | Read article | More about Dr. Jatoi (1-31-12)
Ismail Jatoi, MD, PhD, Chief of Surgical Oncology and Endocrine Surgery interviewed on Texas Public Radio: Dr. Jatoi serves as moderator of the discussion on clinical trials in developing countries for the December 2011 San Antonio Breast Cancer Symposium. Read story on TPR website | More about Dr. Jatoi (12-6-11)
Alfredo Santillan, MD, MPH, interviewed on Laredo NBC affiliate – UT Health Science Center gives presentation on breast cancer: Along with many UTHSCSA and CTRC physicians, Dr. Santillan participated in a cancer education workshop for the public, with a presentation on breast cancer. Ian Thompson, MD, Director of the Cancer Therapy & Research Center, presented information on prostate cancer. More about Dr. Santillan | KGNS-TV, Laredo, TX - Video | Article in La Mañana (en español) (11-1-11)
Alfredo Santillan, MD, MPH, Surgical Oncology, and Raul Ramos, MD, General Surgery,
participate in CTRC Hispanic Cancer Risk lecture:
Drs. Santillan and Ramos will join this month's CTRC presentation from 6-7:30pm, Thursday August 11, 2011.
One of a series of free, monthly public information presentations hosted by the
Cancer Therapy and Research Center, this month's presentation will focus on the special
cancer risks faced by Hispanics. The presentation is open to the public; please call 210-450-1152 for
additional information.
Story links: NowCastSA |
WOAI.com |
HSC News story
|
More about Dr. Santillan
More about Dr. Ramos and Division of General & Laparoendoscopic Surgery
(8-5-11)
Ismail Jatoi, MD, PhD, Chief of Surgical Oncology and Endocrine Surgery,
quoted in Reuters story on disparities in cancer treatment: Researchers
at Walter Reed found that, in spite of
equal access to health care through military health insurance, disparities still
exist between the treatment of black women and white women with breast cancer.
"I think it's important to understand why we're seeing these sorts of variations,"
said Jatoi, who was not involved in this study.
Read Reuters article |
More about Dr. Jatoi
(8-1-11)
The Division of Surgical Oncology is now the Division of Surgical Oncology and Endocrine Surgery: Recently approved by the Medical Dean's Office and the Chairman of the Department of Surgery, the divisional name change reflects the broadening scope of surgical services provided by the surgeons and professional staff. (7-28-11)
Congratulations to Ismail Jatoi, MD, PhD, Chief of UT Surgical Oncology & Endocrine Surgery, who was recently awarded the Legion of Merit for his dedicated service in the US Army, given for exceptionally meritorious conduct in the performance of outstanding services and achievements in the United States military. Dr. Jatoi served in the US Army from 1977 to 2010, serving as head of the National Naval Medical Center Breast Care Center in Bethesda, Maryland, from 2006 through 2010. Upon retirement from the Army in early 2010, Dr. Jatoi joined the Department of Surgery. More about Dr. Jatoi (7-5-11)
Ismail Jatoi, MD, PhD, Chief of Surgical Oncology, UT School of Medicine Department of Surgery, discusses
recent breast cancer study with local news media:
Dr. Jatoi's recently published study, a collaborative research effort with the National Cancer Institute and the
University of Pittsburgh, 'Breast Cancer Adjuvant Therapy: Time to Consider Its Time-Dependent Effects', in
the Journal of Clinical Oncology, suggests that breast cancer treatment medicines begin to lose their effectiveness after
a period of about three years. This study suggests that breast cancer should be treated as a chronic disease, similar to
diabetes or hypertension, and that perhaps new, different drugs that specifically target this stage of the disease need to
be developed.
HSC News article |
KSAT-12 news interview & article |
San Antonio Express-News article |
Journal Article |
(5-12-11; updated 5-19-11)
Alfredo Santillan, MD, MPH, appointed as Cancer Liaison Physician for Audie L. Murphy VA Hospital: The American College of Surgeons (ACS) Commission on Cancer has announced the appointment of Dr. Alfredo Santillan, UT Surgical Oncology, as the Cancer Liaison Physician for Audie L. Murphy VA Hospital, San Antonio, Texas. The ACS Commission on Cancer supports cancer patients and Commission-accredited programs with resources, and includes representatives from more than 1500 cancer programs nationwide. More about the American College of Surgeons Commission on Cancer | More about Dr. Santillan (4-20-11)
Ismail Jatoi, MD, PhD, Chief of Surgical Oncology, UT School of Medicine Department of Surgery, appointments: Dr. Jatoi has been selected to chair the University Health System, San Antonio, TX, Cancer Committee through 2011; he has also been selected to serve on the American Society of Clinical Oncology Health Disparities Advisory Group and the Society of Surgical Oncology Health Disparities Advisory Committee. More about Dr. Jatoi (4-20-11)
Alfredo Santillan, MD, MPH, guest speaker for Society of Nuclear Medicine national meeting and Exito! Latino Cancer Research Leadership Program: Dr. Santillan has been invited to present his abstract, 'Surgical Oncology Imaging', at the 2011 annual meeting of the Society of Nuclear Medicine in San Antonio, TX. The Society of Nuclear Medicine works to improve health care by advancing molecular imaging and therapy. He will also be presenting at the 2011 Exito! Latino Cancer Research Leadership Training Program sponsored by the Institute for Health Promotion Research at the UT Health Science Center San Antonio. More about Dr. Santillan | More about Exito! Latino Cancer Research Leadership Training (4-20-11)
Alfredo Santillan, MD, MPH, receives two appointments in the Society of Surgical Oncology (SSO): Dr. Santillan has been appointed to the SSO Melanoma/Sarcoma Disease Site Workforce through 2012. Created in 2011, the role of this group in the SSO is to assist with development of surgical oncology curriculum, review abstracts, act as a resource for Public Policy Issues & commentary, review guidelines, and develop consensus statements on behalf of the SSO. He has also been named to serve on the Society of Surgical Oncology Training Committee, which, among other activities, assists in the development of surgical oncology training programs and training program guidelines. Visit the Society of Surgical Oncology website (4-13-11)
Alfredo Santillan, MD, MPH, to chair new Cutaneous Oncology Tumor Board: The Cutaneous Oncology Tumor Board will meet the first Monday of each month at 11 am in the Kraus Conference Room (G336), 3rd Floor of the CTRC Grossman Building. More about Dr. Santillan (3-31-11)
CTRC launches community outreach talks on clinical trials: Thursday, April 7, 2011, 9:30 am at the Bob Ross Center, 2219 Babcock Road. An outreach team from the CTRC, part of The University of Texas Health Science Center at San Antonio, will go into the community to talk about what clinical trials have to offer. Read HSC News article | CTRC website (3-24-11)
Ismail Jatoi, MD, PhD, invited speaker — Breast Cancer Screening: Dr. Jatoi will speak to the Hill Country County Medical Society (HCCMS) in Fredericksburg, Texas, in January 2011. Topic will be Breast Cancer Screening. (1-5-11)
HSC News – Experienced surgeons join CTRC's surgical oncology division: 2010 has seen many new developments in Surgery's Division of Surgical Oncology, including three new faculty – Ismail Jatoi, MD, PhD, Professor and Chief; Boyce Oliver, Jr., MD; and Alfredo Santillan, MD. Anatolio Cruz, MD, (pictured, right) founding Surgery faculty member, has been with the division for 40 years. In the news article, he talks about the standards of excellence brought by our new faculty, as well as the changes he's seen in the specialty of surgical oncology over the past four decades. Read HSC News article | CTRC website (11-03-10)
UT Health Science Center San Antonio research study shows risk of combined hormone replacement therapy: Taking combined hormone replacement therapy over a long period of time increases risk of developing breast cancer and also doubles the risk of dying from it. Read HSC News article (11-03-10)
Alfred Santillan, MD, invited to speak at 20th Annual RESToration Retreat, a program of Methodist Healthcare's Woman Plus Family Health and Wellness Program: Dr. Santillan presented "What you need to know about breast cancer". More about Dr. Santillan (10-29-10)
Breast Cancer Awareness Month — The numbers don't lie: Every three seconds, a woman is diagnosed with breast cancer. Every 12 seconds a woman dies of breast cancer. Alfredo Santillan, MD, Assistant Professor, UT Surgical Oncology, discusses breast cancer awareness month on Univision 41 San Antonio. View KWEX-San Antonio Univision video (en español) | More about Dr. Santillan (10-26-10)
Peter Ravdin, MD, PhD, leads CTRC Comprehensive Breast Health Clinic (Mission Magazine)
CTRC Breast Health Clinic: Anatomy of comprehensive care (Mission Magazine)
